References

Allain, J.P., 2004. Occult hepatitis B virus infection: Implications in transfusion. Vox Sang, 86: 83-91.
CrossRef  |  PubMed  |  Direct Link  |  

Asim, M., R. Ali, L.A. Khan, S.A. Husain, R. Singla and P. Kar, 2010. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion. Indian J. Med. Res., 132: 312-317.
Direct Link  |  

Bamaga, M.S., E.I. Azahar, A.K. Al-Ghamdi, F.Q. Alenzi and F.M. Farahat, 2009. Nucleic acid amplification technology for hepatitis B virus and its role in blood donation screening in blood banks. Saudi Med. J., 30: 1416-1421.
PubMed  |  Direct Link  |  

Chemin, I. and C. Trepo, 2005. Clinical impact of occult HBV infections. J. Clin. Virol., 34: S15-S21.
PubMed  |  

El-Sherif, A.M., M.A. Abou-Shady, M.A. Al-Hiatmy, A.M. Al-Bahrawy and E.A. Motawea, 2007. Screening for hepatitis B virus infection in Egyptian blood donors negative for hepatitis B surface antigen. Hepatol. Int., 1: 469-470.
CrossRef  |  

Gartner, B.C., W. Jung, C. Welsch, J. Fischinger and J. Schubert et al, 2007. Permanent loss of anti-HBc after reactivation of hepatitis B virus infection in an anti-HBs and anti-HBc-positive patient after allogeneic stem cell transplantation. J. Clin. Virol., 38: 146-148.
PubMed  |  

Gerlich, W.H., C. Bremer, M. Saniewski, C.G. Schuttler, U.C. Wend, W.R. Willems and D. Glebe, 2010. Occult hepatitis B virus infection: Detection and significance. Dig. Dis., 28: 116-125.
PubMed  |  

Giarcia-Montalvo, B.M., J.A. Farfar-Ale, K.Y. Acosta-Viana and F.I. Puerto-Manzano, 2005. Hepatitis B Virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, Mexico. Transfus. Med., 15: 371-378.
PubMed  |  

Gonzalez, R., P. Torres, E. Castro, L. Barbolla and D. Candotti et al, 2009. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion., 50: 221-230.
PubMed  |  

Hollinger, F.B. and G. Sood, 2010. Occult hepatitis B virus infection: A covert operation. J. Viral. Hepat., 17: 1-15.

Hollinger, F.B., 2008. Hepatitis B virus infection and transfusion medicine: Science and the occult. Transfusion., 48: 1001-1026.
PubMed  |  

Hoofnagle, J.H., L.B. Seeff, Z.B. Bales and H.J. Zimmerman, 1978. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N. Engl. J. Med., 298: 1379-1383.

Kreutz, C., 2002. Molecular, immunological and clinical properties of mutated hepatitis B viruses. J. Cell Mol. Med., 6: 113-143.

Lelie, N. and A. Heaton, 2006. Hepatitis B-a review of the role of NAT in enhancing blood safety. J. Clin. Virol., 36: S1-S2.
PubMed  |  

Levicnik-Stezinar, S., U. Rahne-Potokar, D. Candotti, N. Lelie and J.P. Allain, 2008. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J. Hepatol., 48: 1022-1025.
PubMed  |  

Liaw, Y.F., N. Leung, J.H. Kao, T. Piratvisuth and E. Gane et al, 2008. Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update. Hepatol. Int., 2: 263-283.
PubMed  |  

Liu Y., P. Li, C. Li, J. Zhou, C. Wu and Y.H. Zhou, 2010. Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China. Virol. J., 19: 7-193.

Manzini, P., M. Girotto, R. Borsotti, O. Giachino, R. Guaschino and M. Lanteri et al, 2007. Italian blood donors with anti-HBc and occult hepatitis B infection. Haematol., 92: 1664-1670.
CrossRef  |  

Matsumoto, C., K. Tadokoro, K. Fujimura, S. Hirakawa, S. Mitsunaga and T. Juji, 2001. Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository. Transfusion, 41: 878-884.
PubMed  |  

Niederhauser, C., B.T. Mansouri, M. Graziani, M. Stolz, C. Tinguely and P. Schneider, 2008. Blood donor screening: How to decrease the risk of transfusion-transmitted hepatitis B virus? Swiss Med. Wkly., 138: 134-141.
Direct Link  |  

Raimondo G., J.P. Allain, M.R. Brunetto, M.A. Buendia and D.S. Chen et al, 2008. Statements from the taormina expert meeting on occult hepatitis B virus infection. J. Hepatol., 49: 652-657.
PubMed  |  

Raimondo, G., T. Pollicino, I. Cacciola and G. Squadrito, 2007. Occult hepatitis B virus infection. J. Hepatol., 46: 160-170.
Direct Link  |  

Ramezani, A., M. Banifazl, A. Eslamifar and A. Aghakhani, 2010. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J. Infect. Dev. Ctries. 4: 658-661.
PubMed  |  

Thedja, M.D., M. Roni, A.R. Harahap, N.C. Siregar, S.I. Ie and D.H. Muljono, 2010. Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface protein. Hepatol. Int., 4: 608-614.
CrossRef  |  

Torbenson, M. and D.L. Thomas, 2002. Occult hepatitis B. Lancet Infect. Dis., 2: 479-486.
CrossRef  |  

Wang, J.T., C.Z. Lee, P.J. Chen, T.H. Wang and D.S. Chen, 2002. Transfusion-transmitted HBV infection in an endemic area: The necessity of more sensitive screening for HBV carriers. Transfusion, 42: 1592-1597.
CrossRef  |  

Weber, B., 2006. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J. Med. Virol., 78: S59-S65.
CrossRef  |  PubMed  |  

Yotsuyanagi, H., K. Yasuda, K. Moriya, Y. Shintani and H. Fujie et al., 2001. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion, 41: 1093-1099.
CrossRef  |  PubMed  |  

Yuen, M.F., D.K.Wong, C.K. Lee, Y. Tanaka and J.P. Allain et al., 2011. Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin. Infect. Dis., 52: 624-632.
CrossRef  |  PubMed  |